Partners AIDS Research Center Massachusetts General Hospital

Slides:



Advertisements
Similar presentations
The role of immune responses in HIV-1 Infection Marylyn M. Addo, MD/PhD Partners AIDS Research Center Massachusetts General Hospital Harvard Medical School.
Advertisements

Multi-Faceted Aspects of Acute HIV Infection Concluding remarks Tony Kelleher Kirby Institute & St Vincent’s Centre for Applied Medical Research.
RETROVIRUSES.
HIV: Acute (Primary) Infection. David H
HIV/AIDS Isabelle Récaborde Dr. Frigon Chemistry SL – Block F Option - Medicine and Drugs.
Viruses Chapter Nature of Viruses All viruses have same basic structure -Nucleic acid core surrounded by capsid Nucleic acid can be DNA or RNA;
HIV-1 evolution in response to immune selection pressures
Phylogenetic analysis of HIV-1 Gag cleavage sites polymorphism in HIV acutely infected patients Castro E 1,2, Cavassini M 1, Bart PA 2 and Pantaleo G 2.
Diversity of Living Things
Viruses. Virus: Particles of nucleic acid, protein, some lipids Reproduce vicariously Use the cells they infect to build new viruses.
HIV and Viruses Lucy Stacey Christella. Viruses  Obligate parasites of living cells  Can’t replicate without living host cell  Due to RNApol, ribosomes,
THE GENETICS OF VIRUSES Daniela, Shanayah, Nisma.
Ad5 expressing Gag, Pol and Nef Immune responses in control of HIV replication non-human primates // SIV extrapolated to humans // HIV Prospects for.
Intersubtype differences in the effect of a rare p24 Gag mutation on viral replicative fitness Denis Chopera.
1 Molecular Mechanisms for gp160-Enhanced Apoptosis Keith J. Micoli, Olga A. Mamaeva, George Pan, Eric Hunter and Jay M. McDonald University of Alabama.
Mathias Lichterfeld, M.D., Ph.D. Massachusetts General Hospital An intrinsic inhibitor of p-TEFb and HIV-1 transcriptional elongation in CD4 T cells from.
Viruses Big Questions: What is a virus? How does a virus function?
Virus.
HIV/AIDS.
THE IMMUNE RESPONSES TO VIRUSES
Examining the Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano BIOL398: Bioinformatics Laboratory.
Lecture 19 November 16 th 2010 Quiz 2 scheduled for November 23 rd not November 18th.
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano Bioinformatics Laboratory Loyola.
Ebola Case Study Article Analysis Structure of Viruses Lytic & Lysogenic Cycle HIV & Influenza.
Lecture 13 Immunology and disease: parasite antigenic diversity.
The HIV virus. Objectives At the end of this session the participants will be able to: 1. Understand basic HIV structure 2. Describe the significance.
Evolution and transmission in HIV Steve Paterson Review; Rambaut 2004 Nature Reviews Genetics 5: ‘The causes and consequences of HIV evolution’
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano BIOL398: Bioinformatics Laboratory.
Impact of immune-driven sequence variation in HIV- 1 subtype C Gag-protease on viral fitness and clinical outcome Thumbi Ndung’u, BVM, PhD HIV Pathogenesis.
Exploring Christianity: Forgiveness What is Forgiveness? Our ability to forgive is in direct proportion to our acknowledgement that we’re debtors, too.
Catherine K. Koofhethile 21st IAS July,2016 Durban, SA
Washington State University
The Genetics of Viruses
Influenza and HIV Disease Case Studies Prep Steps Unit 2: Lesson 2.
A flavone-based inhibitor of in vitro human rhinovirus replication induces resistant mutations in capsid protein VP4. Céline Lacroixa, Hari Babu Bollikollac,
Quantifying the Impact of HIV Escape from CTL
Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes by Diana Y. Chen, Arumugam Balamurugan,
Big Questions: What is a virus? How does a virus function?
Free Write What distinguishes ‘The Living’ from ‘The Non-Living’?
Immunology and disease: parasite antigenic diversity
Abnormal Immunity Continued
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Chapter 19- Viruses.
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Mark A Wainberg McGill University AIDS Centre Jewish General Hospital
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Monique Nijhuis University Medical Center Utrecht, the Netherlands
Volume 38, Issue 3, Pages (March 2013)
Volume 4, Issue 5, Pages (May 1996)
Figure 3 Hypothetical mechanisms of smoking-associated
The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
The protective compared to other B. Rodés,
HIV Immunology Goes Out On a Limb
O. Turriziani, M. Andreoni, G. Antonelli 
The Rational Design of an AIDS Vaccine
Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy  Steven G. Deeks, Bruce D. Walker 
Etiology of Type 1 Diabetes
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Evolution and transmission in HIV
New developments in laboratory monitoring of HIV-1 infection
Double Trouble: HIV Latency and CTL Escape
HIV and HLA Class I: An Evolving Relationship
Volume 15, Issue 3, Pages (April 2016)
Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation
Chloe Jones, Isabel Gonzaga, and Nicole Anguiano
Volume 18, Issue 2, Pages (February 2003)
Volume 27, Issue 1, Pages e4 (April 2019)
Cytotoxicity of p5399–107-induced CTL cells.
-supported study By Dr. Chao Peng
Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease
Presentation transcript:

Partners AIDS Research Center Massachusetts General Hospital HLA-B27-Associated Escape Mutations Dramatically Reduce Viral Fitness of HIV-1 Arne Schneidewind Partners AIDS Research Center Massachusetts General Hospital Boston

Background • HLA-B27 is a “protective” MHC class I allele in HIV infection - Genetic effect observed late in disease (Gao et al, Nat Med., 2005) - immunodominant CD8 response targets KK10 in p24 capsid - CTL escape mutations in KK10 occur very late in disease • Studies have illustrated that drug resistance mutations and CD8 escape mutations can impact viral replication Hypothesis The effect of CD8 escape mutations on viral fitness may contribute to immune control associated with HLA-B27

Goals • Examine the impact of CD8 escape mutations in B27- KK10 (KRWIILGLNK) on HIV-1 replicative fitness • Assess the ability of compensatory mutations to rescue the fitness defects of a CD8 escape mutation • Explore mechanisms for the late escape from this immunodominant CD8 T cell response

Viral Escape in B27-KK10 • Various CD8 escape and compensatory mutations in KK10 have been previously described : Goulder et al Nature Med 1997; Kelleher et al JEM 2001; Goulder et al Nature 2001; Feeney et al JVI 2004; Ammaranond et al AIDS Res Hum Retroviruses 2005 Upstream mutation 90 aa

Viral Escape in B27-KK10 • Various CD8 escape and compensatory mutations in KK10 have been previously described : Goulder et al Nature Med 1997; Kelleher et al JEM 2001; Goulder et al Nature 2001; Feeney et al JVI 2004; Ammaranond et al AIDS Res Hum Retroviruses 2005 Upstream mutation 90 aa • L268M occurs early after infection and is a weak CD8 escape mutation

Viral Escape in B27-KK10 • Various CD8 escape and compensatory mutations in KK10 have been previously described : Goulder et al Nature Med 1997; Kelleher et al JEM 2001; Goulder et al Nature 2001; Feeney et al JVI 2004; Ammaranond et al AIDS Res Hum Retroviruses 2005 Upstream mutation 90 aa • Mutation R264K at the anchor position P2 diminishes binding to HLA-B27 and represents the predominant CD8 escape mutation in KK10

Viral Escape in B27-KK10 • Various CD8 escape and compensatory mutations in KK10 have been previously described : Goulder et al Nature Med 1997; Kelleher et al JEM 2001; Goulder et al Nature 2001; Feeney et al JVI 2004; Ammaranond et al AIDS Res Hum Retroviruses 2005 Upstream mutation 90 aa • An upstream compensatory mutation (S173A) has been proposed - Kelleher / Brander (manuscript in preparation)

Compensatory Mutation lies in Proximity to Escape Mutations N-term p24 capsid

Compensatory Mutation lies in Proximity to Escape Mutations N-term p24 capsid R264K L268M

Compensatory Mutation lies in Proximity to Escape Mutations N-term p24 capsid S173A

Escape Mutation R264K Reduces Infectivity - 12% - 96% Replace with powerpoint title Xhrs post infection Assay to measure p24

Escape Mutation R264K Reduces Replicative Capacity can we split this into 2 figures? First with WT, LM, RK, SA 2nd adding in RKLM, SARKLM Let’s talk about the insert too... Need to highlight SA reduction too

Escape Mutation R264K Reduces Replicative Capacity can we split this into 2 figures? First with WT, LM, RK, SA 2nd adding in RKLM, SARKLM Let’s talk about the insert too... Need to highlight SA reduction too

Escape Mutation R264K Reduces Replicative Capacity can we split this into 2 figures? First with WT, LM, RK, SA 2nd adding in RKLM, SARKLM Let’s talk about the insert too... Need to highlight SA reduction too

Escape Mutation R264K Reduces Replicative Capacity can we split this into 2 figures? First with WT, LM, RK, SA 2nd adding in RKLM, SARKLM Let’s talk about the insert too... Need to highlight SA reduction too

Reduces p24 Production on PBMCs Escape Mutation R264K Reduces p24 Production on PBMCs

Escape Mutation R264K doesn’t alter Release of p24

Escape Mutation R264K doesn’t alter Cleavage of Gag WT RK SARKLM WT RK SARKLM p24  p55  p24  supernatant intracellular

Conclusions CD8 escape mutation R264K exhibits a dramatic defect in infectivity and replicative capacity Upstream mutation S173A in helix 2 effectively compensates for the fitness defect of R264K • The dramatic fitness cost of R264K, and the requirement for a simultaneous compensatory mutation, may explain the late escape from this CD8 response R264K variant seems to be blocked at an early step of the replicative cycle Add in the ability of other upstream compensatory mutations to rescue other KK10 mutations (data not shown)

This project was supported by NIH Grant R21 AI067078 Acknowledgment Mark A. Brockman Sylvie Le Gall Rahma I. Adam Matthew P. Lahaie Christian Brander Tony Kelleher Bruce D. Walker Todd M. Allen This project was supported by NIH Grant R21 AI067078